Glucotrack, Inc.
Glucotrack, Inc.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | |||||||||||||||||
Assets | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 1 | 4 | 7 | 8 | 10 | 9 | 6 | 0 | 0 | 1 | 4 | 7 | |||||
Other Assets Current | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Assets Current | 1 | 4 | 8 | 8 | 10 | 9 | 6 | 1 | 0 | 2 | 5 | 7 | |||||
Operating Lease Right Of Use Asset | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | |||||
Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Restricted Cash Noncurrent | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Assets | 1 | 4 | 8 | 8 | 10 | 10 | 6 | 1 | 1 | 2 | 5 | 7 | |||||
Liabilities | |||||||||||||||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Accounts Payable Current | 1 | 1 | 1 | 2 | 3 | 2 | 1 | 2 | 3 | 1 | 1 | 1 | |||||
Notes Payable Current | - | - | - | - | - | - | - | - | 0 | - | - | - | |||||
Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | |||||
Convertible Notes Payable Current | - | - | - | - | - | 0 | 0 | 0 | - | - | - | - | |||||
Derivative Liabilities | - | - | - | - | - | - | - | 0 | - | - | - | - | |||||
Other Notes Payable Current | 2 | 3 | 3 | 3 | - | - | - | - | - | - | - | - | |||||
Other Liabilities Current | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 0 | |||||
Liabilities Current | 3 | 5 | 5 | 5 | 3 | 2 | 1 | 5 | 4 | 1 | 2 | 1 | |||||
Liabilities Noncurrent | |||||||||||||||||
Derivative Liabilities Noncurrent | - | - | 0 | 0 | 0 | 0 | 17 | - | - | - | - | - | |||||
Operating Lease Liability Noncurrent | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | |||||
Other Liabilities Noncurrent | - | - | 0 | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Liabilities Noncurrent | - | - | - | - | - | - | - | - | - | - | - | 0 | |||||
Long Term Loans Payable | 0 | 0 | - | 0 | 0 | 0 | - | - | - | - | - | - | |||||
Liabilities | 3 | 5 | 5 | 6 | 3 | 2 | 19 | 5 | 4 | 2 | 2 | 2 | |||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital Common Stock | 158 | 155 | 151 | 151 | 151 | 146 | 119 | 118 | 114 | 113 | 113 | 113 | |||||
Stockholders Equity | |||||||||||||||||
Accumulated Other Comprehensive Income Loss Net Of… | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | |||||
Retained Earnings Accumulated Deficit | -160 | -156 | -152 | -148 | -144 | -139 | -132 | -122 | -117 | -113 | -110 | -107 | |||||
Stockholders Equity | -2 | -1 | 3 | 3 | 7 | 7 | -13 | -4 | -3 | 0 | 3 | 6 | |||||
Liabilities And Stockholders Equity | 1 | 4 | 8 | 8 | 10 | 10 | 6 | 1 | 1 | 2 | 5 | 7 | |||||
Common Stock Par Or Stated Value Per Share | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | |||||
Common Stock Shares Authorized | 250 | 250 | 250 | 250 | 250 | 250 | 100 | 100 | 100 | 500 | 100 | 500 | |||||
Common Stock Shares Issued | 6 | 3 | 1 | 1 | 1 | 26 | 13 | 6 | 5 | 27 | 0 | 21 | |||||
Shares Outstanding | 6 | 3 | 1 | 1 | 1 | 26 | 13 | 6 | 5 | 27 | 0 | 21 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -9.55% | -52.24% | -28.81% | - | - | - | - | - | - | - | - | - |
| 2025 | -4.00% | -26.44% | -30.78% | -14.51% | 29.37% | 13.11% | 5.82% | -31.57% | -66.31% | -3.17% | -33.95% | -51.25% |
| 2024 | 16.40% | -29.55% | -44.94% | 80.33% | 46.97% | 18.45% | -17.21% | -4.87% | -79.22% | -8.57% | -24.00% | -39.81% |
| 2023 | - | - | - | - | - | - | 52.83% | 50.94% | 30.82% | 147.73% | 51.06% | 45.02% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 0.46 | 0.85 | 1.61 | 1.53 | 3.27 | 4.85 | 4.52 | 0.14 | 0.12 | 1.31 | 3.22 | 4.93 | |||||
| Quick Ratio | 0.46 | 0.85 | 1.61 | 1.53 | 3.27 | 4.85 | 4.52 | 0.14 | 0.12 | 1.31 | 3.22 | 4.93 | |||||
| Working Capital | -1.61M | -761.00K | 2.89M | 2.81M | 6.99M | 7.51M | 4.49M | -3.97M | -3.22M | 455.00K | 3.36M | 5.72M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | -1.86 | -6.12 | 1.77 | 2.01 | 0.48 | 0.32 | -1.46 | -1.21 | -1.18 | 4.60 | 0.53 | 0.29 | |||||
| Debt Ratio | 2.16 | 1.20 | 0.64 | 0.67 | 0.33 | 0.24 | 3.19 | 5.87 | 6.41 | 0.82 | 0.35 | 0.23 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | 3.18 | 10.31 | 31.22 | 28.75 | 54.14 | 156.50 | 4.11 | 3.20 | 2.64 | 35.01 | 34.19 | 1.30 | |||||
| Free Cash Flow Per Share TTM | -3.26 | -10.03 | -24.69 | -16.54 | -29.05 | -74.06 | -2.29 | -2.47 | -2.02 | -33.04 | -31.59 | -1.11 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Growth Metrics | |||||||||||||||||
| Net Income Growth (1Y) | -40.43% | -36.28% | -14.20% | 73.34% | 122.14% | 203.31% | 218.40% | 149.75% | 157.67% | 88.81% | 60.02% | -25.05% | |||||
| EPS Growth (1Y) | -94.12% | -93.41% | 660.19% | 798.69% | 1,950.22% | 347.05% | -87.99% | 146.04% | 143.45% | 11,627.65% | 11,827.98% | 152.46% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | 0.10 | 0.06 | 0.12 | 0.23 | 0.11 | 0.07 | 109.00 | 904.15 | 913.48 | 56.73 | 45.98 | 1,213.82 | |||||
| P/B TTM | -0.92 | -1.25 | 0.85 | 2.15 | 0.43 | 0.24 | -189.47 | -3,352.91 | -3,347.03 | 1,318.36 | 102.08 | 1,304.46 | |||||
| Market Cap | 1.60M | 1.06M | 2.40M | 5.93M | 2.97M | 1.78M | 2.46B | 13.49B | 11.01B | 495.70M | 326.35M | 7.25B | |||||
| Enterprise Value | 473.90K | -2.86M | -4.98M | -1.94M | -6.59M | -7.31M | 2.46B | 13.49B | 11.01B | 494.20M | 321.86M | 7.24B | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -16.31M | -16.44M | -15.34M | -14.88M | -14.37M | -12.54M | -12.59M | -11.51M | -9.21M | -8.25M | -6.56M | -5.09M | |||||
| Net Debt | -1.12M | -3.93M | -7.38M | -7.87M | -9.56M | -9.09M | -5.61M | -341.00K | -147.00K | -1.50M | -4.49M | -6.89M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
Glucotrack, Inc. (GCTK) — SEC Financial Statements & Analysis
Glucotrack, Inc. (GCTK) is a surgical & medical instruments & apparatus company, incorporated in DE. Glucotrack, Inc. trades on Nasdaq as: GCTK. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Glucotrack, Inc. reported a Debt-to-Equity ratio of -1.86x, a Price-to-Book (P/B) ratio of -0.92x (TTM), at a market cap of $1.60M. Figures below are sourced from SEC EDGAR, as-filed.
- Debt To Equity
- -1.86x
- P/B TTM
- -0.92x
- Market Cap
- $1.60M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Glucotrack, Inc. in?
Glucotrack, Inc. (GCTK) operates in the Surgical & Medical Instruments & Apparatus industry.
What is GCTK's market cap?
Glucotrack, Inc. (GCTK) has a market capitalization of $1.60M as of 2026-06-30.
What is GCTK's P/E ratio?
Glucotrack, Inc. (GCTK)'s trailing twelve month P/E ratio is 0.10x as of 2026-06-30.
What exchange does GCTK trade on?
Glucotrack, Inc. (GCTK) trades on the Nasdaq.
Where is Glucotrack, Inc. incorporated?
Glucotrack, Inc. is incorporated in DE.